A PYMNTS Company

US: Gilead sued for drug price-gouging

By  |  December 11, 2014

A Philadelphia transportation company filed a lawsuit against pharmaceutical conglomerate Gilead for what it claims are “exorbitant” drug prices.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    According to reports, the Southeastern Pennsylvania Transportation Authority claims Gilead abused its patent monopoly on the Sovaldi drug, which treats Hepatitis C. The suit, filed Tuesday, argues that the $1,000 cost for a single pill is the result of Gilead’s “limited rights as a patent holder,” which “do not translate into a license to price gouge consumers.”

    The transportation authority says it has spent more than $2.4 million on Sovaldi for its employees. The company is now seeking to represent a nationwide class in legal action against Gilead.

    The SPTA is seeking an unspecified amount of money damages, according to reports.

    Full content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.